Modalis Therapeutics (TSE:4883) Price-to-Operating-Cash-Flow : (As of Jun. 09, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Modalis Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-09), Modalis Therapeutics's share price is 円70.00. Modalis Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was 円0.00. Hence, Modalis Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Modalis Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 6 years, Modalis Therapeutics's highest Price-to-Operating-Cash-Flow Ratio was 461.11. The lowest was 0.00. And the median was 0.00.

TSE:4883's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 16.11
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Modalis Therapeutics's Cash Flow from Operations per share for the three months ended in Mar. 2024 was 円0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was 円0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -72.10% per year.

During the past 6 years, Modalis Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was -49.30% per year. The lowest was -72.10% per year. And the median was -60.70% per year.

Modalis Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Modalis Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modalis Therapeutics Price-to-Operating-Cash-Flow Chart

Modalis Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Modalis Therapeutics Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial														-	-	-	-	-

Competitive Comparison of Modalis Therapeutics's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Modalis Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Modalis Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modalis Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Modalis Therapeutics's Price-to-Operating-Cash-Flow falls into.

Modalis Therapeutics Price-to-Operating-Cash-Flow Calculation

Modalis Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	70.00	/	0
	=

Modalis Therapeutics's Share Price of today is 円70.00.
Modalis Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Modalis Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Modalis Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Modalis Therapeutics (TSE:4883) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modalis Therapeutics Corp (TSE:4883) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

16-5 Nihombashi-Kabuto-cho, Chuo-ku, Tokyo, JPN, 103-0026

Website

https://www.modalistx.com

Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.

Modalis Therapeutics (TSE:4883) Headlines

No Headlines